Quite remarkably, the two genes upregulated in this module (DHCR7 and UBE2C) are two members of the EndoPredict assay, an RT-PCR assay for predicting response to endocrine treatment in ER+/HER2 − breast cancer [35,36]. The gene discussed is UBE2C; the disease is breast carcinoma.